FREMONT, Calif., Feb. 5, 2026 /PRNewswire/ -- Lam Research Corporation (Nasdaq: LRCX) today announced that its Board of Directors has approved a quarterly dividend of $0.26 per share of common stock.
We believe Lam Research (LRCX) stock could be an attractive investment option. Why? Because it offers strong margin, a low-debt capital structure, and strong momentum in recent months – with potential for growth as the stock currently trades below its 52-week high following a sharp sell off earlier this week.
FREMONT, Calif., Feb. 3, 2026 /PRNewswire/ -- Lam Research Corp. (Nasdaq: LRCX) today announced it is elevating the roles of two proven leaders as the company enters its next phase of growth.
FREMONT, Calif., Feb. 3, 2026 /PRNewswire/ -- Lam Research Corp. (NASDAQ: LRCX) today announced that Dr. Anirudh Devgan has joined its board of directors.
New Multi-Year Agreement Will Focus on Accelerating Pathfinding of New Materials and Processes for the Manufacturing of More Energy-Efficient Specialty Devices FREMONT, Calif. and GRENOBLE, France, Feb. 2, 2026 /PRNewswire/ -- Lam Research Corp. (Nasdaq: LRCX), a leader in semiconductor fabrication equipment and services and CEA-Leti, a research institute pioneering micro- and nanotechnologies,...
Among our top contributors in Q4 were Argenx, Lam Research and Insmed. Among our biggest detractors in Q4 were Oracle, Netflix and BAE Systems. During the quarter, we initiated new positions in RTX (Raytheon), Capital One and Somnigroup. In addition to Insmed and BAE, we also added to L3Harris, a global aerospace and defense company.
aktien.guide ist das Tool zum einfachen Finden, Analysieren und Beobachten von Aktien. Lerne von erfolgreichen Investoren und triff fundierte Anlageentscheidungen. Wir machen Dich zum selbstbestimmten Investor.